https://www.selleckchem.com/pr....oducts/ly3023414.htm
vention had a 0.28% reduction. Those assigned to the control group had a 0.16% reduction in HbA1c. Conclusions A novel mobile-delivered DPP achieved significant weight loss reductions for up to 1 year compared with usual care. This type of intervention reduces the risk of overt diabetes without the added barriers of in-person interventions. Clinicaltrial Clinicaltrials.gov NCT03865342; https//clinicaltrials.gov/ct2/show/NCT03865342.Background Although mobile health (mHealth) has the potential to transform health care by delivering bet